RENAL OUTCOMES IN POST-LIVER TRANSPLANT RECIPIENTS TREATED WITH TENOFOVIR ALAFENAMIDE COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR

被引：0
|
作者：
Liu, Joanne [1 ]
Vutien, Philip [2 ]
Huang, Daniel [3 ,4 ]
Ishigami, Masatoshi [5 ]
Daniel, Peter Chen Yang Nikhil [6 ]
Ito, Takanori [5 ]
Dang, Hansen [7 ]
Maeda, Mayumi [7 ]
Leong, Jennifer [8 ]
Landis, Charles [9 ]
Nguyen, Mindie H. [7 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Univ Washington, Div Gastroenterol, Seattle, WA 98195 USA
[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore
[4] Natl Univ Singapore Hosp, Div Gastroenterol & Hepatol, Singapore, Singapore
[5] Nagoya Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Nagoya, Aichi, Japan
[6] Natl Univ Singapore Hosp, Dept Med, Singapore, Singapore
[7] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA
[8] Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, Recanati Miller Transplantat Inst, New York, NY 10029 USA
[9] Univ Washington, Div Gastroenterol & Hepatol, Seattle, WA 98195 USA
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
802
引用
收藏
页码：492A / 493A
页数：2
相关论文
共 50 条
  • [41] Comparison of body weight and lipid profiles following tenofovir disoproxil fumarate or entecavir switchingto tenofovir alafenamide in chronic hepatitis B patients
    Cheng, Pin-Nan
    Liu, Chun-Jen
    Chen, Jyh-Jou
    Feng, I-Cher
    Kuo, Hsing-Tao
    Lee, Pei-Lun
    Yu, Ming-Lung
    Chiu, Yencheng
    Hung-Chih, Chiu
    Chien, Shih-Chieh
    Chen, Pei-Jer
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1140 - S1141
  • [42] The Impact of Tenofovir Disoproxil Fumarate on Reduced Bone Mineral Density and Fractures in Liver Transplant Recipients
    Lim, N.
    Jackson, S.
    Engler, C.
    Lake, J. R.
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (01) : 215 - 220
  • [43] TENOFOVIR ALAFENAMIDE VS. TENOFOVIR DISOPROXIL FUMARATE OR ENTECAVIR FOR HEPATITIS B IN SOUTH AFRICA: A COST-EFFECTIVE AND BUDGETIMPACT ANALYSIS
    Carapinha, Joao
    Sonderup, Mark W.
    Wearne, Nicola
    HEPATOLOGY, 2022, 76 : S292 - S293
  • [44] TENOFOVIR ALAFENAMIDE VERSUS TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: LIVER- RELATED CLINICAL OUTCOMES AND SUBGROUP ANALYSIS BY LIVER CIRRHOSIS STATUS
    Kim, Soon Sun
    Seo, Gi Hyeon
    Han, Ji Eun
    Cho, Hyo Jung
    Kim, Eunju
    Yoon, Eileen
    Jang, Eun Sun
    Chang, Jong-In
    Cho, Young Youn
    Lee, Hyung Woong
    Cheong, Jae Youn
    Kim, Hyung Joon
    HEPATOLOGY, 2024, 80 : S168 - S168
  • [45] Metabolic Outcomes of Changing From Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine to Rilpivirine/Tenofovir Alafenamide/Emtricitabine: A Longitudinal Study
    Wu, Ping-Feng
    Lin, Hsi-Hsun
    Chen, Hsin-Pai
    Huang, Po-Chieh
    Ke, Meng-Yu
    HEALTH SCIENCE REPORTS, 2024, 7 (12)
  • [46] Does switching to tenofovir alafenamide fumarate impair recovery of renal function in individuals newly diagnosed with tenofovir disoproxil fumarate induced renal tubular toxicity?
    Agrawal, N.
    Murphy, M.
    Booth, J.
    HIV MEDICINE, 2019, 20 : 276 - 277
  • [47] The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile
    Squillace, Nicola
    Ricci, Elena
    Menzaghi, Barbara
    De Socio, Giuseppe Vittorio
    Passerini, Simone
    Martinelli, Canio
    Mameli, Maria Sabrina
    Maggi, Paolo
    Falasca, Katia
    Cordier, Laura
    Celesia, Benedetto Maurizio
    Salomoni, Elena
    Di Biagio, Antonio
    Pellicano, Giovanni Francesco
    Bonfanti, Paolo
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 5515 - 5520
  • [48] Comparison of Tenofovir Alafenamide and Entecavir Therapy in Patients with Chronic Hepatitis B Initially Treated with Tenofovir Disoproxil: A Retrospective Observational Survey
    Kalkan, Irem Akdemir
    Karasahin, Omer
    Sarigul, Figen
    Toplu, Sibel Altunisik
    Aladag, Murat
    Akgul, Fethiye
    Mete, Ayse Ozlem
    Golbol, Abdullah
    Nazik, Selcuk
    Komur, Suheyla
    Oren, Meryem Merve
    Yildiz, Yesim
    Demir, Yakup
    Ayhan, Merve
    Tasova, Yesim
    Bayindir, Yasar
    Dal, Tuba
    Celen, Mustafa K.
    HEPATITIS MONTHLY, 2021, 21 (10)
  • [49] COST-EFFECTIVENESS OF SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE TO TENOFOVIR ALAFENAMIDE VS. ENTECAVIR FOR CHRONIC HEPATITIS B PATIENTS IN GREECE
    Sinakos, E.
    Kachru, N.
    Tsoulas, C.
    Jeyakumar, S.
    Smith, N.
    Yehoshua, A.
    Cholongitas, E.
    VALUE IN HEALTH, 2023, 26 (06) : S82 - S83
  • [50] Efficacy and Safety of Entecavir and/or Tenofovir for Prophylaxis and Treatment of Hepatitis B Recurrence Post-Liver Transplant
    Jimenez-Perez, M.
    Saez-Gomez, A. B.
    Mongil Poce, L.
    Lozano-Rey, J. M.
    de la Cruz-Lombardo, J.
    Rodrigo-Lopez, J. M.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (08) : 3167 - 3168
12345